Malign Hipertermi
Referanslar
Yang L, Tautz T Shulin Z, . The current status of malignant hyperthermia .The Journal of Biomedical Research 2020;34(2):75-85
Rosenberg H, Pollock N, Schiemann A, et al. Malignant hyperthermia: a review. Orphanet J Rare Dis. ;2015 Aug 4;10:93 doi: 10.1186/s13023-015-0310-1.
Butterworth JF, Mackey DC, Wasnick JD.(2021) Klinik Anesteziyoloji(Handan Cuhruk, Çev. Ed.) Bölüm 52 Termoregülasyon, Hipotermi, ve Malign Hipertermi 1213-1221Ankara: Güneş Tıp Kitapevleri
Klingler W, Heiderich, Girard T, et al. Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study. Orphanet J Rare Dis. 2014 Jan 16;9:8. Doi: 10.1186/1750-1172-9-8.
TARD (2015) Türk Anesteziyoloji ve Reanimasyon Derneği Anestezi Uygulama Kılavuzları Malign Hipertermi Krizini Tanıma ve Yönetim Kılavuzu (10.12.2021 tarihinde https://www.tard.org.tr/assets/kilavuz/malignhipetermi.pdf adresinden ulaşılmıştır.)
Nelson TE, Sweo T. Ca2+ uptake and Ca2+ release by skeletal muscle sarcoplasmic reticulum: differing sensitivity to inhalational anesthetics. Anesthesiology. 1988 Oct;69(4):571-7.Doi: 10.1097/00000542-198810000-00018.
Lai FA, Meissner G .The muscle ryanodine receptor and its intrinsic Ca2+ channel activity. J Bioenerg Biomembr. 1989 Apr;21(2):227-46. doi: 10.1007/BF00812070.
Wappler F. Malignant hyperthermia. Eur J Anaesthesiol. 2001 Oct;18(10):632-52. doi: 10.1046/j.1365-2346.2001.00888.x.
Coronado R, Morrissette J, Sukhareva M, et al.Structure and function of ryanodine receptors.Am J Physiol. 1994 Jun;266(6 Pt 1):C1485-504. doi: 10.1152/ajpcell.1994.266.6.C1485.
W Melzer , Herrmann-Frank A, Lüttgau HC. The role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fibres Biochim Biophys Acta. 1995 May 8;1241(1):59-116. doi: 10.1016/0304-4157(94)00014-5.
Nelson P, Litman RS. Malignant hyperthermia in children: an analysis of the North American malignant hyperthermia registry Anesth Analg. 2014 Feb;118(2):369-374. doi: 10.1213/ANE.0b013e3182a8fad0.
lahn KP, Ellis FR, Halsall PJ, et al. European Malignant Hyperthermia Group.Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth. 2010 Oct;105(4):417-20. doi: 10.1093/bja/aeq243.
Ergil J. (2016). Malign Hipertermi. Yüksel Keçik (Ed.),Temel Anestezi içinde (1107-1119) Ankara:Güneş Tıp Kitapevleri
Karan SM,Crowl F, Muldoon SM. Malignant hyperthermia masked by capnographic monitoring. Anesthesia and Analgesia, 01 Mar 1994, 78(3):590-2 doi: 10.1213/00000539-199403000-00029.
Schwartz L, Rockoff MA, Koka BV. Masseter spasm with anesthesia: incidence and implications. Anesthesiology 1984 Dec;61(6):772-5. doi: 10.1097/00000542-198412000-00025.
O'Flynn RP 1, Shutack JG, Rosenberg H, et al. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. Anesthesiology.1994 Jun;80(6):1228-33. doi: 10.1097/00000542-199406000-00009.
Nelson TE. Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses. Anesthesiology. 1990 Sep;73(3):449-54.
Sessler DI,Warner DS et. al. Temperature monitoring and perioperative thermoregulation. Anesthesiology. August 2008: 109(2):318–338 doi: 10.1097/ALN.0b013e31817f6d76.
Güncel Anestezi (2010). Malign Hipertermi ve Anestezi (10.12.2021 tarihinde https://guncelanestezi.com/2010/05/malign-hipertermi-ve-anestezi/ adresinden ulaşılmıştır.
